Paydirt
Insider filing · TARS

Dianne C. Whitfield sold $1.1M of Tarsus Pharmaceuticals (TARS)

Executed Jan 2, disclosed Jan 6, 4 days later.

Value, as filed
$1.1M
13,837 sh across 2 lots
Executed
Jan 2
the trade date, as filed
Disclosed
Jan 6
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
purchases only

Returns are measured on stock purchases only.

The filer
DW Dianne C. Whitfield Chief Human Resources Officer profile →

Dianne C. Whitfield (Chief Human Resources Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $1.1M of TARS (13,837 sh across 2 lots, as filed), executed Jan 2.

The name
TARS Tarsus Pharmaceuticals, Inc. TARS · Healthcare · 35 filings in 24 months ticker →

Healthcare · Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic…

More Healthcare filings Insider filings, newest first View the original filing at www.sec.gov
Other filings by Dianne C. Whitfield in TARS
TARSSALE Tarsus Pharmaceuticals, Inc. $839K
12,274 sh across 3 lots
Exec Mar 17
Filed Mar 19 · 5:30 PM ET
TARSSALE Tarsus Pharmaceuticals, Inc. $592K
7,397 sh × $80.10
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET
TARSSALE Tarsus Pharmaceuticals, Inc. $321K
6,711 sh across 3 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET